Palvella Therapeutics (PVLA) Payables: 2013-2024
Historic Payables for Palvella Therapeutics (PVLA) over the last 11 years, with Sep 2024 value amounting to $801,000.
- Palvella Therapeutics' Payables fell 71.56% to $801,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $4.2 million, marking a year-over-year decrease of 79.30%. This contributed to the annual value of $936,000 for FY2023, which is 77.47% down from last year.
- As of Q3 2024, Palvella Therapeutics' Payables stood at $801,000, which was down 17.34% from $969,000 recorded in Q2 2024.
- Palvella Therapeutics' Payables' 5-year high stood at $19.7 million during Q3 2021, with a 5-year trough of $801,000 in Q3 2024.
- In the last 3 years, Palvella Therapeutics' Payables had a median value of $3.6 million in 2022 and averaged $4.8 million.
- Per our database at Business Quant, Palvella Therapeutics' Payables skyrocketed by 170.65% in 2021 and then crashed by 87.26% in 2024.
- Palvella Therapeutics' Payables (Quarterly) stood at $7.7 million in 2020, then climbed by 11.36% to $8.6 million in 2021, then tumbled by 51.75% to $4.2 million in 2022, then slumped by 77.47% to $936,000 in 2023, then crashed by 71.56% to $801,000 in 2024.
- Its last three reported values are $801,000 in Q3 2024, $969,000 for Q2 2024, and $1.5 million during Q1 2024.